Program 1: Breast Cancer

乳腺癌项目 项目摘要/摘要 乳腺癌计划的主要目标是降低乳腺癌的死亡率和发病率。 该计划致力于四个核心领域的研究，这些领域可能对 乳腺癌的治疗：1)三阴性乳腺癌，2)HER2+乳腺癌，3)脑 转移，以及年轻女性中出现的乳腺癌。这些领域的每一个都建立在强有力的研究基础上 总部设在DF/HCC，汇集了来自几个学科和多个机构的研究人员。这个 该计划有116名成员，代表7个DF/HCC机构和17个学术部门。2014年 来自NCI的同行评审赠款资金总额为980万美元，另有780万美元 来自其他赞助商的100万美元。在当前的资助期间，乳腺癌计划成员发布了 1750篇与癌症相关的论文。其中33%是机构间的，26%是方案内的，46%是方案内的 是两个或更多DF/CC成员之间的方案间协作。总体而言，当计算一次时， 27%的DF/CC出版物是方案间合作。

Breast Cancer Program Project Summary / Abstract The primary goal of the Breast Cancer Program is to reduce mortality and morbidity from breast cancer. The program is committed to research in four core areas that could have a significant impact on the treatment of patients with breast cancer: 1) triple negative breast cancer, 2) HER2+ breast cancer, 3) brain metastases, and 4) breast cancer arising in young women. Each of these areas builds on a strong research base at DF/HCC and brings together investigators from several disciplines and multiple institutions. The program has 116 members, representing seven DF/HCC institutions and 17 academic departments. In 2014 peer-reviewed grant funding attributed to the Program was $9.8 million in total costs from the NCI and $7.8 million from other sponsors. During the current funding period, Breast Cancer Program members published 1,750 cancer-relevant papers. Of these 33% were inter-institutional, 26% were intra-programmatic, and 46% were inter-programmatic collaborations between two or more DF/HCC members. Overall, when counted once, 27% of DF/HCC publications were inter-programmatic collaborations.